Kyverna Therapeutics Inc.

2.16
0.03 (1.41%)
At close: Apr 24, 2025, 3:59 PM
2.04
-5.56%
Pre-market: Apr 25, 2025, 08:47 AM EDT

Kyverna Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
96.62M 104.66M 131.62M 224.29M 34.65M 22.97M 224.29M -51.32M 37.73M
189.36M 216.92M 214.62M 145.51M 22.9M 54.31M 145.51M 102.64M 13.59M
n/a n/a 574K 570K 565K n/a n/a n/a 554K
3.39M 2.44M 1.21M 1.17M 3.36M 2M 1.74M -51.32M 678K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
4.62M 3.79M 2.59M 5.69M 3.12M 2.14M n/a n/a 1.93M
290.6M 325.37M 348.82M 375.49M 60.66M 79.41M 375.49M 51.32M 53.25M
10.66M 11.38M 12.51M 12.75M 10.61M 11.07M 12.75M n/a 12.44M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
14.04M 13.82M 14.29M 14.5M 14.53M 13.08M 14.5M -51.32M 13.67M
304.64M 339.2M 363.12M 389.98M 75.19M 92.49M 389.98M n/a 66.92M
4.62M 9.93M 4.86M 7.45M 4.36M 3.02M 7.45M n/a 1.45M
n/a n/a n/a n/a 9.06M 8.11M n/a n/a 7.66M
n/a 3.93M 3.87M 3.72M n/a n/a n/a n/a n/a
4.88M 4.44M 8.15M 5.62M 9.77M 4.81M n/a n/a 6.82M
33.76M 30.98M 23.48M 21.86M 19.86M 16.87M 21.86M n/a 11.95M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 296K n/a n/a 180.57M 180.57M n/a n/a 120.68M
4.3M 5.5M 6.13M 7.13M 186.73M 187.42M 7.13M n/a 128.97M
38.06M 36.49M 29.61M 28.99M 206.59M 204.29M 28.99M n/a 140.92M
8.24M 9.14M 10M 10.85M 9.08M 9.64M 10.85M n/a 10.56M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-263.52M -226.03M -191.54M -162.74M -136.04M -115.38M -162.74M n/a -75.68M
105K 153K -37K -1K 4K 5K -1K -74M -26K
266.59M 302.71M 333.51M 360.99M -131.4M -111.81M 360.99M 46.68M -74M
189.36M 216.92M 215.19M 145.51M 22.9M 54.31M 145.51M 102.64M 13.59M